| Literature DB >> 21845094 |
Huitao Fan1, Baoan Song, Pinaki S Bhadury, Linhong Jin, Deyu Hu, Song Yang.
Abstract
Using half-leaf method O,O'-diisopropyl (3-(L-1-(benzylamino)-1-oxo-3- phenylpropan-2-yl)thioureido)(phenyl)methyl phosphonate (2009104) was studied for its activity on tobacco mosaic virus (TMV). It showed good curative activity in vivo and the curative activity at 500 μg/mL was found to be 53.3%. In vivo treatment with the control agent Ningnanmycin at 500 μg/mL resulted in 51.2% inhibition and curative inhibition rates respectively. Dot-ELISA test was employed to verify the efficacy of activity of compound 200910 for anti-TMV activity. The mechanism of action of compound 2009104 to resist TMV was also studied. The results showed that the resistance enzymes PAL, POD, SOD activity and chlorophyll content after TMV inoculation K(326) (Nicotiana tabacum K(326)) of tobacco plants followed by treatment with compound 2009104 were significantly enhanced. The study of the effect of compound 2009104 on TMV capsid protein (CP) showed that it inhibited the polymerization process of TMV-CP in vitro.Entities:
Keywords: antiviral activity; chiral thiourea compounds; mechanism of action; tobacco mosaic virus
Mesh:
Substances:
Year: 2011 PMID: 21845094 PMCID: PMC3155367 DOI: 10.3390/ijms12074522
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1The molecular structure of 2009104.
The result of curative, protective and inactivation efficacies of compound 2009104 against TMV.
| Pharmacy Name | Average inhibition rate (%)
| ||
|---|---|---|---|
| Curative effect | Protective effect | Inactivation effect | |
| 2009104 (500 μg/mL) | 53.3 | 58.9 | 84.9 |
| Ningnanmycin AS (500 μg/mL) | 51.2 | 62.6 | 88.4 |
Figure 2The inhibitory effect of compound 2009104 on TMV in tobacco assayed by Dot-ELISA test.
Figure 3PAL activity in tobacco leaves in differential treatment groups T1: CK; T2: TMV; T3: TMV+ Ningnanmycin; T4: TMV + 2009104.
Figure 4POD activity in tobacco leaves in differential treatment groups T1: CK; T2: TMV; T3: TMV+ Ningnanmycin; T4: TMV+2009104.
Figure 5SOD activity in tobacco leaves in differential treatment groups T1: CK; T2: TMV; T3: TMV+ Ningnanmycin; T4: TMV+2009104.
Figure 6Changes of chlorophyll content in leaves treated with compound 2009104 T1: TMV; T2: CK; T3: TMV+Ningnanmycin; T4: TMV+2009104.
Figure 7SDS-PAGE of TMV-CP Lane 1: Protein molecular weight marker; Lane 2: TMV-CP; Lane 3: TMV-CP.
Figure 8UV (320 nm) absorption of TMV coat-protein polymerization in vitvo treated with compound 2009104 at different time intervals T1: TMV-CP; T2: 2009104 +TMV-CP; T3: Ribavirin +TMV-CP.